Efficacy of Granulocyte Colony Stimulating Factor in Reducing First Trimester Miscarriages in Women With a History of Recurrent Pregnancy Loss: A Systematic Review and Meta‐Analysis
American Journal of Reproductive Immunology · 2025
DOI: 10.1111/aji.70189 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Maren Bettermann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Iowa Health Care, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Abortion, Habitual, Granulocyte Colony-Stimulating Factor. Die Arbeit nennt 49 Literaturangaben.
Abstract (Originalsprache)
Purpose
Several studies have evaluated a wide range of immunomodulatory therapies for treatment of unexplained recurrent pregnancy loss (RPL) and granulocyte colony stimulating factor (G‐CSF) is a new addition. We aimed to perform a cumulative meta‐analysis to update and reevaluate the efficacy of the use of G‐CSF to reduce the risk of first trimester miscarriages in women with a history of RPL.
Methods
We searched electronic databases until September 26, 2024. We screened 309 citations and included six randomized control trials (RCTs) and four observational cohort studies. A total of 800 women were included in the analysis for the primary outcome; 426 (53%) women had treatment with G‐CSF and 374 (47%) women had placebo or no treatment.
Results
Women who were administered GCSF in early pregnancy had a statistically significant reduction in miscarriage compared to those who had placebo or no treatment, odds ratio [95% CI] = 0.4 [0.3; 0.7]. A subsequent significant increase in live birth was also found in women who had GCSF, odds ratio [95% CI] = 2.3 [1.4; 3.6].
Conclusion
Among women with a history of recurrent pregnancy loss, administration of granulocyte colony stimulating factor resulted in statistically significant reduction in first trimester miscarriage and subsequent improvement in live birth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Iowa Health Care, Iowa City, Iowa, USA.
- REI Division, Department of Obstetrics and Gynecology, University of Iowa Health Care, Iowa City, Iowa, USA.
- Hardin Library for the Health Sciences, University of Iowa, Iowa City, Iowa, USA.
- Institute For Clinical and Translational Science, Department of Biostatistics, University of Iowa Health Care, Iowa City, Iowa, USA.
Zitieren
APA
Bettermann, M., Carlisle, A., Summers, K., Childs, C., Eyck, P. T., & Eapen, A. (2025). Efficacy of Granulocyte Colony Stimulating Factor in Reducing First Trimester Miscarriages in Women With a History of Recurrent Pregnancy Loss: A Systematic Review and Meta‐Analysis. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70189
Vancouver
Bettermann M, Carlisle A, Summers K, Childs C, Eyck PT, Eapen A. Efficacy of Granulocyte Colony Stimulating Factor in Reducing First Trimester Miscarriages in Women With a History of Recurrent Pregnancy Loss: A Systematic Review and Meta‐Analysis. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70189
BibTeX
@article{Bettermann2025,
author = {Bettermann, Maren and Carlisle, Allison and Summers, Karen and Childs, Christopher and Eyck, Patrick Ten and Eapen, Abey},
title = {Efficacy of Granulocyte Colony Stimulating Factor in Reducing First Trimester Miscarriages in Women With a History of Recurrent Pregnancy Loss: A Systematic Review and Meta‐Analysis},
journal = {American Journal of Reproductive Immunology},
year = {2025},
doi = {10.1111/aji.70189}
}
EUVIMED